{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:20:58Z","timestamp":1788956458142,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00535-017-1333-2","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T08:00:36Z","timestamp":1491033636000},"page":"655-662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Geoepidemiology and changing mortality in primary biliary cholangitis"],"prefix":"10.1007","volume":"52","author":[{"given":"Annarosa","family":"Floreani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,1]]},"reference":[{"key":"1333_CR1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","volume":"52","author":"R Poupon","year":"2010","unstructured":"Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol. 2010;52:745\u201358.","journal-title":"J Hepatol"},{"key":"1333_CR2","unstructured":"Addison, Gull. On a certain affliction of the skin\u2014vitiligoides\u2014a planus tuberosa. Guy\u2019s hosp rev. 1857;7:268\u2013274."},{"key":"1333_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-195012000-00002","volume":"29","author":"EH Ahrens Jr","year":"1950","unstructured":"Ahrens EH Jr, Payne MA, Kunkel HG, Eisenmenger WJ, Blondheim SH. Primary biliary cirrhosis. Medicine (Baltimore). 1950;29:299\u2013364.","journal-title":"Medicine (Baltimore)"},{"key":"1333_CR4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0016-5085(19)35377-6","volume":"37","author":"S Sherlock","year":"1959","unstructured":"Sherlock S. Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology. 1959;37:574\u201386.","journal-title":"Gastroenterology"},{"key":"1333_CR5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","volume":"1","author":"JG Walker","year":"1965","unstructured":"Walker JG, Doniach D, Roitt IM, Sherlock S. Serological tests in diagnosis of primary biliary cirrhosis. Lancet. 1965;1:827\u201331.","journal-title":"Lancet"},{"key":"1333_CR6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","volume":"324","author":"RE Poupon","year":"1991","unstructured":"Poupon RE, Balkau B, Eschwege E, Poupon R, UDCA\u2014PBC Study Group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med. 1991;324:1548\u201354.","journal-title":"N Engl J Med"},{"key":"1333_CR7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, Strasser SI, Bowlus C, Invernizzi P, Drenth JP, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375:631\u201343.","journal-title":"N Engl J Med"},{"key":"1333_CR8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gut.15.6.473","volume":"15","author":"AN Hamlyn","year":"1974","unstructured":"Hamlyn AN, Sherlock S. The epidemiology of primary biliary cirrhosis: a survey of mortality in England and Wales. Gut. 1974;15:473\u20139.","journal-title":"Gut"},{"key":"1333_CR9","first-page":"377","volume":"75","author":"M Myszor","year":"1990","unstructured":"Myszor M, James OF. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease? Q J Med. 1990;75:377\u201385.","journal-title":"Q J Med"},{"key":"1333_CR10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.510300213","volume":"30","author":"OF James","year":"1999","unstructured":"James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology. 1999;30:390\u20134.","journal-title":"Hepatology"},{"key":"1333_CR11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/ije\/26.4.830","volume":"26","author":"JV Metcalf","year":"1997","unstructured":"Metcalf JV, Bhopal RS, Gray J, Howel D, James OF. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne. England. Int J Epidemiol. 1997;26:830\u20136.","journal-title":"Int J Epidemiol"},{"key":"1333_CR12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/gut.36.6.927","volume":"36","author":"RG Watson","year":"1995","unstructured":"Watson RG, Angus PW, Dewar M, Goss B, Sewell RB, Smallwood RA. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. Gut. 1995;36:927\u201330.","journal-title":"Gut"},{"key":"1333_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","volume":"127","author":"S Sood","year":"2004","unstructured":"Sood S, Gow PJ, Christie JM, Angus PW. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology. 2004;127:470\u20135.","journal-title":"Gastroenterology"},{"key":"1333_CR14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1478-3231.2010.02366.x","volume":"31","author":"A Floreani","year":"2011","unstructured":"Floreani A, Caroli D, Variola A, Rizzotto ER, Antoniazzi S, Chiaramonte M, Cazzagon N, et al. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int. 2011;31:361\u20138.","journal-title":"Liver Int"},{"key":"1333_CR15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","volume":"53","author":"MI Prince","year":"2004","unstructured":"Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut. 2004;53:865\u201370.","journal-title":"Gut"},{"key":"1333_CR16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MEG.0b013e328353753d","volume":"24","author":"TR Baldursdottir","year":"2012","unstructured":"Baldursdottir TR, Bergmann OM, Jonasson JG, Ludviksson BR, Axelsson TA, Bjornsson ES. The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study. Eur J Gastroenterol Hepatol. 2012;24:824\u201330.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1333_CR17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.23210","volume":"50","author":"RP Myers","year":"2009","unstructured":"Myers RP, Shaheen AA, Fong A, Burak KW, Wan A, Swain MG, Hilsden RJ, et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology. 2009;50:1884\u201392.","journal-title":"Hepatology"},{"key":"1333_CR18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/MEG.0b013e328277594a","volume":"19","author":"X Pla","year":"2007","unstructured":"Pla X, Vergara M, Gil M, Dalmau B, Cistero B, Bella RM, Real J. Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. Eur J Gastroenterol Hepatol. 2007;19:859\u201364.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1333_CR19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","volume":"20","author":"TC Mahl","year":"1994","unstructured":"Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24\u00a0years. J Hepatol. 1994;20:707\u201313.","journal-title":"J Hepatol"},{"key":"1333_CR20","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","volume":"98","author":"K Balasubramaniam","year":"1990","unstructured":"Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology. 1990;98:1567\u201371.","journal-title":"Gastroenterology"},{"key":"1333_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365528909092240","volume":"24","author":"A Nyberg","year":"1989","unstructured":"Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease. Scand J Gastroenterol. 1989;24:57\u201364.","journal-title":"Scand J Gastroenterol"},{"key":"1333_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1572-0241.1999.00770.x","volume":"94","author":"J Springer","year":"1999","unstructured":"Springer J, Cauch-Dudek K, O\u2019Rourke K, Wanless IR, Heathcote EJ. Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol. 1999;94:47\u201353.","journal-title":"Am J Gastroenterol"},{"key":"1333_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0016-5085(85)90325-7","volume":"89","author":"DR Beswick","year":"1985","unstructured":"Beswick DR, Klatskin G, Boyer JL. Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history. Gastroenterology. 1985;89:267\u201371.","journal-title":"Gastroenterology"},{"key":"1333_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198301063080101","volume":"308","author":"J Roll","year":"1983","unstructured":"Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med. 1983;308:1\u20137.","journal-title":"N Engl J Med"},{"key":"1333_CR25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology"},{"key":"1333_CR26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","volume":"128","author":"C Corpechot","year":"2005","unstructured":"Corpechot C, Carrat F, Bahr A, Chretien Y, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology. 2005;128:297\u2013303.","journal-title":"Gastroenterology"},{"key":"1333_CR27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Pares","year":"2006","unstructured":"Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology. 2006;130:715\u201320.","journal-title":"Gastroenterology"},{"key":"1333_CR28","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","volume":"101","author":"PC Borg ter","year":"2006","unstructured":"ter Borg PC, Schalm SW, Hansen BE, van Buuren HR. Dutch PBCSG. Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-year cohort study involving 297 patients. Am J Gastroenterol. 2006;101:2044\u201350.","journal-title":"Am J Gastroenterol"},{"key":"1333_CR29","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1572-0241.2007.01235.x","volume":"102","author":"Y Gong","year":"2007","unstructured":"Gong Y, Huang Z, Christensen E, Gluud C. Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. Am J Gastroenterol. 2007;102:1799\u2013807.","journal-title":"Am J Gastroenterol"},{"key":"1333_CR30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2005-916323","volume":"25","author":"YM Lee","year":"2005","unstructured":"Lee YM, Kaplan MM. The natural history of PBC: has it changed? Semin Liver Dis. 2005;25:321\u20136.","journal-title":"Semin Liver Dis"},{"issue":"7","key":"1333_CR31","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers WJ, Hirschfield GM, Corpechot C, Nevens F, Lindor KD, Janssen HL, et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015;149(7):1804\u201312","journal-title":"Gastroenterology."},{"key":"1333_CR32","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone M, Sharp SJ, Flack S, Paximadas D, Spiess K, Adgey C, et al. The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology. 2016;63:930\u201350","journal-title":"Hepatology."},{"key":"1333_CR33","doi-asserted-by":"publisher","unstructured":"Samur S, Hur C, Klebanoff M, Pratt D, Banken R, Chapman R, Ollendorf D, et al. Long-term clinical outcomes and cost-effectiveness of obeticholic acid for treatment of primary biliary cholangitis. Hepatology. 2017;65(3):920\u20138. doi: 10.1002\/hep.28932 .","DOI":"10.1002\/hep.28932"},{"key":"1333_CR34","unstructured":"Cholankeril G, Perumpail R, Wong R, Yoo E, Hu M, Jayasckera C. Predictors of waitlist outcomes in candidates with primary biliary cholangitis awaiting liver transplantation. Hepatology. 2016;Suppl. 1:(Abst 207)."},{"key":"1333_CR35","doi-asserted-by":"publisher","unstructured":"Singal AK, Fang X, Kaif M, Hasanin M, McGuire BM, Kuo YF, Wiesner RH. Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation. Transpl Int. 2016. doi: 10.1111\/tri.12877 .","DOI":"10.1111\/tri.12877"},{"key":"1333_CR36","first-page":"266","volume":"8","author":"K Boonstra","year":"2014","unstructured":"Boonstra K, Bokelaar R, Stadhouders PH, Tuynman HA, Poen AC, van Nieuwkerk KM, Witteman EM, et al. Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36\u00a0years. Hepatol Int. 2014;8:266\u201374.","journal-title":"Hepatol Int"},{"key":"1333_CR37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","volume":"48","author":"A Floreani","year":"2015","unstructured":"Floreani A, Franceschet I, Cazzagon N, Spinazze A, Buja A, Furlan P, Baldo V, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol. 2015;48:192\u20137.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1333_CR38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12016-014-8446-7","volume":"48","author":"A Floreani","year":"2015","unstructured":"Floreani A, Spinazze A, Caballeria L, Reig A, Cazzagon N, Franceschet I, Buja A, et al. Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers. Clin Rev Allergy Immunol. 2015;48:254\u201362.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1333_CR39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pcad.2016.07.012","volume":"59","author":"P Vassallo","year":"2016","unstructured":"Vassallo P, Driver SL, Stone NJ. Metabolic syndrome: an evolving clinical construct. Prog Cardiovasc Dis. 2016;59:172\u20137.","journal-title":"Prog Cardiovasc Dis"},{"key":"1333_CR40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MCG.0000000000000029","volume":"49","author":"A Floreani","year":"2015","unstructured":"Floreani A, Cazzagon N, Franceschet I, Canesso F, Salmaso L, Baldo V. Metabolic syndrome associated with primary biliary cirrhosis. J Clin Gastroenterol. 2015;49:57\u201360.","journal-title":"J Clin Gastroenterol"},{"key":"1333_CR41","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/hep.25788","volume":"56","author":"Y Liang","year":"2012","unstructured":"Liang Y, Yang Z, Zhong R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology. 2012;56:1409\u201317.","journal-title":"Hepatology"},{"key":"1333_CR42","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/hep.22178","volume":"47","author":"FD Mendes","year":"2008","unstructured":"Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD. Mortality attributable to cholestatic liver disease in the United States. Hepatology. 2008;47:1241\u20137.","journal-title":"Hepatology"},{"key":"1333_CR43","doi-asserted-by":"crossref","first-page":"25906","DOI":"10.1038\/srep25906","volume":"6","author":"A Lleo","year":"2016","unstructured":"Lleo A, Jepsen P, Morenghi E, Carbone M, Moroni L, Battezzati PM, Podda M, et al. Evolving trends in female to male incidence and male mortality of primary biliary cholangitis. Sci Rep. 2016;6:25906.","journal-title":"Sci Rep"},{"key":"1333_CR44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","volume":"65","author":"PJ Trivedi","year":"2016","unstructured":"Trivedi PJ, Lammers WJ, van Buuren HR, Pares A, Floreani A, Janssen HL, Invernizzi P, et al. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut. 2016;65:321\u20139.","journal-title":"Gut"},{"key":"1333_CR45","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/hep.26176","volume":"57","author":"K Harada","year":"2013","unstructured":"Harada K, Hirohara J, Ueno Y, Nakano T, Kakuda Y, Tsubouchi H, Ichida T, et al. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan. Hepatology. 2013;57:1942\u20139.","journal-title":"Hepatology"},{"key":"1333_CR46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","volume":"48","author":"G Rong","year":"2015","unstructured":"Rong G, Wang H, Bowlus CL, Wang C, Lu Y, Zeng Z, Qu J, et al. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis. Clin Rev Allergy Immunol. 2015;48:132\u201341.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1333_CR47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","volume":"144","author":"M Carbone","year":"2013","unstructured":"Carbone M, Mells GF, Pells G, Dawwas MF, Newton JL, Heneghan MA, Neuberger JM, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology. 2013;144:560\u20139.","journal-title":"Gastroenterology"},{"key":"1333_CR48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2007;45:118\u201327.","journal-title":"Hepatology"},{"key":"1333_CR49","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hep.21678","volume":"45","author":"DP Bogdanos","year":"2007","unstructured":"Bogdanos DP, Liaskos C, Pares A, Norman G, Rigopoulou EI, Caballeria L, Dalekos GN, et al. Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology. 2007;45:1583; author reply 1583\u20134.","journal-title":"Hepatology"},{"key":"1333_CR50","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.dld.2011.05.005","volume":"43","author":"A Floreani","year":"2011","unstructured":"Floreani A, Cazzagon N, Martines D, Cavalletto L, Baldo V, Chemello L. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis. 2011;43:887\u201392.","journal-title":"Dig Liver Dis"},{"key":"1333_CR51","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.22517","volume":"48","author":"MJ Mayo","year":"2008","unstructured":"Mayo MJ, Parkes J, Adams-Huet B, Combes B, Mills AS, Markin RS, Rubin R, et al. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology. 2008;48:1549\u201357.","journal-title":"Hepatology"},{"key":"1333_CR52","doi-asserted-by":"crossref","unstructured":"Olmez S, Sayar S, Avcioglu U, Tenlik I, Ozaslan E, Koseoglu HT, Altiparmak E. The relationship between liver histology and noninvasive markers in primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 2016;28(7):773\u20136.","DOI":"10.1097\/MEG.0000000000000637"},{"key":"1333_CR53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.dld.2015.10.024","volume":"48","author":"C Stasi","year":"2016","unstructured":"Stasi C, Leoncini L, Biagini MR, Arena U, Madiai S, Laffi G, Marra F, et al. Assessment of liver fibrosis in primary biliary cholangitis: comparison between indirect serum markers and fibrosis morphometry. Dig Liver Dis. 2016;48:298\u2013301.","journal-title":"Dig Liver Dis"},{"key":"1333_CR54","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21151","volume":"43","author":"C Corpechot","year":"2006","unstructured":"Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, de Ledinghen V, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118\u201324.","journal-title":"Hepatology"},{"key":"1333_CR55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","volume":"56","author":"C Corpechot","year":"2012","unstructured":"Corpechot C, Carrat F, Poujol-Robert A, Gaouar F, Wendum D, Chazouilleres O, Poupon R. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology. 2012;56:198\u2013208.","journal-title":"Hepatology"},{"key":"1333_CR56","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2036.2007.03585.x","volume":"27","author":"E Gomez-Dominguez","year":"2008","unstructured":"Gomez-Dominguez E, Mendoza J, Garcia-Buey L, Trapero M, Gisbert JP, Jones EA, Moreno-Otero R. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther. 2008;27:441\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"1333_CR57","doi-asserted-by":"publisher","unstructured":"Koizumi Y, Hirooka M, Abe M, Tokumoto Y, Yoshida O, Watanabe T, Nakamura Y, et al. Comparison between real-time tissue elastography and vibration-controlled transient elastography for the assessment of liver fibrosis and disease progression in patients with primary biliary cholangitis. Hepatol Res. 2017. doi: 10.1111\/hepr.12861 .","DOI":"10.1111\/hepr.12861"},{"key":"1333_CR58","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/gut.52.8.1200","volume":"52","author":"E Giannini","year":"2003","unstructured":"Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, Mele MR, et al. Platelet count\/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52:1200\u20135.","journal-title":"Gut"},{"key":"1333_CR59","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2015.07.010","volume":"63","author":"Z Bian","year":"2015","unstructured":"Bian Z, Miao Q, Zhong W, Zhang H, Wang Q, Peng Y, Chen X, et al. Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: implications for autoimmune and non-autoimmune liver disease. J Autoimmun. 2015;63:76\u201387.","journal-title":"J Autoimmun"},{"key":"1333_CR60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaut.2015.10.005","volume":"66","author":"YH Hsueh","year":"2016","unstructured":"Hsueh YH, Chang YN, Loh CE, Gershwin ME, Chuang YH. AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis. J Autoimmun. 2016;66:89\u201397.","journal-title":"J Autoimmun"},{"key":"1333_CR61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2015.08.011","volume":"66","author":"K Hudspeth","year":"2016","unstructured":"Hudspeth K, Donadon M, Cimino M, Pontarini E, Tentorio P, Preti M, Hong M, et al. Human liver-resident CD56bright\/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J Autoimmun. 2016;66:40\u201350.","journal-title":"J Autoimmun"},{"key":"1333_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.11.004","volume":"66","author":"R Liberal","year":"2016","unstructured":"Liberal R, Selmi C, Gershwin ME. Diego and Giorgina Vergani: the two hearts of translational autoimmunity. J Autoimmun. 2016;66:1\u20136.","journal-title":"J Autoimmun"},{"key":"1333_CR63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaut.2015.10.006","volume":"66","author":"Q Wang","year":"2016","unstructured":"Wang Q, Yang F, Miao Q, Krawitt EL, Gershwin ME, Ma X. The clinical phenotypes of autoimmune hepatitis: a comprehensive review. J Autoimmun. 2016;66:98\u2013107.","journal-title":"J Autoimmun"},{"key":"1333_CR64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2015.01.011","volume":"59","author":"YH Wang","year":"2015","unstructured":"Wang YH, Yang W, Yang JB, Jia YJ, Tang W, Gershwin ME, Ridgway WM, et al. Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis. J Autoimmun. 2015;59:26\u201337.","journal-title":"J Autoimmun"},{"key":"1333_CR65","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2015.09.002","volume":"66","author":"JB Yang","year":"2016","unstructured":"Yang JB, Wang YH, Yang W, Lu FT, Ma HD, Zhao ZB, Jia YJ, et al. Successful treatment of murine autoimmune cholangitis by parabiosis: implications for hematopoietic therapy. J Autoimmun. 2016;66:108\u201317.","journal-title":"J Autoimmun"},{"key":"1333_CR66","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.28641","volume":"64","author":"HR Bae","year":"2016","unstructured":"Bae HR, Leung PS, Tsuneyama K, Valencia JC, Hodge DL, Kim S, Back T, et al. Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology. 2016;64:1189\u2013201.","journal-title":"Hepatology"},{"key":"1333_CR67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28359","volume":"64","author":"GM Hirschfield","year":"2016","unstructured":"Hirschfield GM, Gershwin ME, Strauss R, Mayo MJ, Levy C, Zou B, Johanns J, et al. Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study. Hepatology. 2016;64:189\u201399.","journal-title":"Hepatology"},{"key":"1333_CR68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nrgastro.2016.201","volume":"14","author":"GJ Webb","year":"2017","unstructured":"Webb GJ, Hirschfield GM. Primary biliary cholangitis in 2016: high-definition PBC: biology, models and therapeutic advances. Nat Rev Gastroenterol Hepatol. 2017;14:76\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1333_CR69","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","volume":"63","author":"M Carbone","year":"2016","unstructured":"Carbone M, Sharp SJ, Flack S, Paximadas D, Spiess K, Adgey C, Griffiths L, et al. The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology. 2016;63:930\u201350.","journal-title":"Hepatology"},{"key":"1333_CR70","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12016-014-8419-x","volume":"48","author":"GM Hirschfield","year":"2015","unstructured":"Hirschfield GM, Siminovitch KA. Genetics in PBC: what do the \u201crisk genes\u201d teach us? Clin Rev Allergy Immunol. 2015;48:176\u201381.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1333_CR71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jhep.2013.04.010","volume":"59","author":"I Patanwala","year":"2013","unstructured":"Patanwala I, McMeekin P, Walters R, Mells G, Alexander G, Newton J, Shah H, et al. A validated clinical tool for the prediction of varices in PBC: the Newcastle Varices in PBC Score. J Hepatol. 2013;59:327\u201335.","journal-title":"J Hepatol"},{"key":"1333_CR72","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","volume":"35","author":"H Liu","year":"2010","unstructured":"Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, Vergani D, et al. PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010;35:436\u201342.","journal-title":"J Autoimmun"},{"key":"1333_CR73","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/j.ejim.2012.09.004","volume":"23","author":"JS Delgado","year":"2012","unstructured":"Delgado JS, Vodonos A, Delgado B, Jotkowitz A, Rosenthal A, Fich A, Novack V. Primary biliary cirrhosis in southern Israel: a 20\u00a0years follow up study. Eur J Intern Med. 2012;23:e193\u20138.","journal-title":"Eur J Intern Med"},{"key":"1333_CR74","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","volume":"20","author":"T Mahl","year":"1994","unstructured":"Mahl T, Shockcor W, Boyer J. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol. 1994;20:707\u201313.","journal-title":"J Hepatol"},{"key":"1333_CR75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1572-0241.1999.00770.x","volume":"94","author":"J Springer","year":"1999","unstructured":"Springer J, Cauch-Dudek K, O\u2019Rourke K, Wanless I, Heathcote E. Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol. 1999;94:47\u201353.","journal-title":"Am J Gastroenterol"},{"key":"1333_CR76","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","volume":"53","author":"M Prince","year":"2004","unstructured":"Prince M, Chetwynd A, Craig W, Metcalf J, James O. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut. 2004;53:865\u201370.","journal-title":"Gut"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-017-1333-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T14:02:42Z","timestamp":1568988162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-017-1333-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,1]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1007\/s00535-017-1333-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,1]]}}}